Jingyu Li, Yu Zhao, Yan Zheng, Xuexia Zhang, Ya Jiang, Jiangshu Guo, Wenmei Bao, Yinfeng Ma, Yaoyuan Zhang, Shuyuan Yin, Yirui Ma, Lijie Wang, Xiaoqiang Liu. A Randomized, Double-Blind, Positive-Controlled Phase III Clinical Trial of an Anti-Rabies Monoclonal Antibody for Category III Rabies Exposure in Individuals Under 18 Years — China, 2021–2023J. China CDC Weekly, 2026, 8(17): 513-519. DOI: 10.46234/ccdcw2026.082
|
Citation:
|
Jingyu Li, Yu Zhao, Yan Zheng, Xuexia Zhang, Ya Jiang, Jiangshu Guo, Wenmei Bao, Yinfeng Ma, Yaoyuan Zhang, Shuyuan Yin, Yirui Ma, Lijie Wang, Xiaoqiang Liu. A Randomized, Double-Blind, Positive-Controlled Phase III Clinical Trial of an Anti-Rabies Monoclonal Antibody for Category III Rabies Exposure in Individuals Under 18 Years — China, 2021–2023J. China CDC Weekly, 2026, 8(17): 513-519. DOI: 10.46234/ccdcw2026.082
|
Jingyu Li, Yu Zhao, Yan Zheng, Xuexia Zhang, Ya Jiang, Jiangshu Guo, Wenmei Bao, Yinfeng Ma, Yaoyuan Zhang, Shuyuan Yin, Yirui Ma, Lijie Wang, Xiaoqiang Liu. A Randomized, Double-Blind, Positive-Controlled Phase III Clinical Trial of an Anti-Rabies Monoclonal Antibody for Category III Rabies Exposure in Individuals Under 18 Years — China, 2021–2023J. China CDC Weekly, 2026, 8(17): 513-519. DOI: 10.46234/ccdcw2026.082
|
Citation:
|
Jingyu Li, Yu Zhao, Yan Zheng, Xuexia Zhang, Ya Jiang, Jiangshu Guo, Wenmei Bao, Yinfeng Ma, Yaoyuan Zhang, Shuyuan Yin, Yirui Ma, Lijie Wang, Xiaoqiang Liu. A Randomized, Double-Blind, Positive-Controlled Phase III Clinical Trial of an Anti-Rabies Monoclonal Antibody for Category III Rabies Exposure in Individuals Under 18 Years — China, 2021–2023J. China CDC Weekly, 2026, 8(17): 513-519. DOI: 10.46234/ccdcw2026.082
|
DownLoad: